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Chip electrospray mass spectrometry for
carbohydrate analysis
Currently two types of chip systems are used in conjunction with MS: out-of-plane
devices, where hundreds of nozzles, nanospray emitters are integrated onto a single
silicon substrate from which electrospray is established perpendicular to the substrate,
and planar microchips, embedding a microchannel at the end of which electrospray is
generated in-plane, on the edge of the microchip. In the last two years, carbohydrate
research greatly benefited from the introduction and implementation of the chip-based
MS. In two laboratories the advantages of the chip electrospray in terms of ionization
efficiency, sensitivity, reproducibility, quality of data in combination with high mass
accuracy, and resolution of detection were systematically explored for several carbo-
hydrate classes: O- and N-glycopeptides, oligosaccharides, gangliosides and glyco-
protein-derived O- and N-glycans, and glycopeptides. The current state-of-the-art in
interfacing the chip electrospray devices to high-performance MS for carbohydrate
analysis, and the particular requirements for method optimization in both positive and
negative ion modes are reviewed here. The recent applications of these miniaturized
devices and their general potential for glycomic-based surveys are highlighted.
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1 Introduction
In the development of miniaturized microfluidic systems a
significant progress in the past decade took place primarily
due to numerous advantages of microchip analysis,
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including the ability to analyze minute samples, the
increased throughput and performance, as well as
reduced costs. In addition, several laboratory procedures
such as sample preparation, purification, separation, and
detection have been integrated onto a single microchip
unit forming the so-called micro-total analysis systems
(mTAS) to allow enhancement in sensitivity, speed, and
accuracy [1–4]. In the last years, by introducing MS as a
detector, the potential and the applicability of mTAS have
been significantly extended [5, 6]. On the other hand, the
option for miniaturized, integrated devices for sample
infusion into MSwas driven by several technical, analytical,
and economical advantages such as simplification of the
laborious chemical and biochemical strategies required
currently for MS research, minimization of sample handling
and sample loss, elimination of possible cross-contamina-
tion, increased ionization efficiency, high quality of spectra,
possibility for unattended high-throughput experiments,
and the flexibility provided by the microchips for coupling
to different MS configurations.
In the field of ESI–MS, two types of chip-based devices are
currently being investigated. The first category is repre-
sented by the out-of-plane devices, where 100 or 400
nanospray emitters are integrated onto a single silicon
substrate, from which electrospray is established perpen-
dicular to the substrate [7]. These devices are amenable to
high-throughput sample delivery to ESI-MS by automated
infusion [8, 9] and have the potential to completely replace
flow-injection analysis assays. Moreover, the technical
quality of the nanosprayers obtained by advanced silicon
microtechnology is so high, and the experiments so re-
producible, that such devices have been found in some
instances to give more robust and quantitative analyses
than LC- or CE-MS and to be able to suppress the need for
separation prior to MS analysis [10, 11].
Due to efficient ionization properties, silicon-based
nanoESIchip/MS preferentially forms multiply charged
ions, and the in-source fragmentation of labile groups
attached to the main structural backbone is minimized,
enhancing the sensitivity of the analysis.
The second category consists of planar or thin micro-
chips, made from glass [12, 13] or polymer [14, 15] mate-
rial, embedding a microchannel at the end of which elec-
trospray is generated in-plane, on the edge of the micro-
chip. During the last years, the progress in polymer-based
microsprayer systems was promoted by development of
simpler methods for accurate plastic replications and
ease to create lower-cost disposable chips.
Though compatible to automation for high-throughput
analysis, these designs are best suited to act like mTAS by
integration of other analytical functions prior to sample
delivery to the MS system, such as sample cleanup [16],
analyte separation by CE [17], and chemical tagging [18].
Moreover, in comparison with glass nanospray capil-
laries, these thin microsprayers were found to provide
superior stability of the spray with time, improved S/N at
various flow rates.
Several approaches for interfacing MS to silicon, glass, or
polymer chips, providing flow rates which include them in
categories from nano- to microsprayers, were reported
[19]. Different configurations such as single and triple
quadrupole, TOF, IT, and ultrahigh-resolution Fourier-
transform ion cyclotron resonance (FTICR) mass spec-
trometers were adapted to chip-based ESI and con-
tributed significant benefits for various studies. However,
as nicely illustrated already by a number of reviews [8, 11,
20–22] the general areas of implementation and applica-
tions of chip technologies either silicon-based, glass, or
polymer microchips have by far been primarily genomics,
drug discovery, and proteomics.
Carbohydrates are the most abundant class of organic
components found in living organisms, characterized by a
high degree of structural complexity. They are present in
nature as either oligosaccharides or glycoconjugates in
which the oligosaccharide portion is covalently linked to a
protein and/or a lipid and occur ubiquitously displayed on
macromolecules and the surface of cells. This biopolymer
category is involved in basic biological functions, such as
antigen recognition machinery, cellular adhesion of bac-
teria and viruses, and protein folding, stability, and traf-
ficking [23]. Particular structures were found to represent
biomarkers of severe diseases and others to play an
essential role in fertilization and embryogenesis [24].
Despite the high biological importance of carbohydrates
and the performance exhibited by chip-based MS meth-
odologies, the glycomics field has benefited from the chip
technology only to a limited extent. Optimization of ESI-
chip/MS for operation in the negative ion mode to detect
carbohydrate ions was considered a challenging task
mostly due to the relative low ionization efficiency that
ultimately leads to decreased sensitivity. Besides, each
class of carbohydrates was shown to require particular
and defined conditions for chip ionization followed by the
MS detection. These conditions are strongly dependent
on the type of the labile peripheral attachments on the
sugar chain such as fucosylation, sialylation, sulfation,
phosphorylation, the ionizability of the functional groups,
the hydrophilic and/or hydrophobic nature, branching of
the sugar chains etc. [25, 26].
However, during the past years, efforts have been invest-
ed toward implementation of chipESI-MS/MS in gly-
comics. Initial experiments for testing of general tech-
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niques and methodology provided clear-cut evidence for
high potential in applications of this technology to re-
search projects requiring compositional and structural
analysis of N- and O-glycans, O-glycopeptides, and
gangliosides.
In this context, the purpose of a review highlighting the
first achievements and trends in chip-based ESI-MS of
carbohydrates is primarily to offer a general background
for its better understanding and the motivations for such
an analytical option. We believe that from this review the
reader will learn the basic requirements for successful
chip MS analysis of different carbohydrate categories and
disclose the advantages of chip-based ESI-MS devices
for their compositional and structural assays.
2 Thin chip polymer-based electrospray MS
2.1 Coupling of the thin chip microsprayer
system to high-performance MS for
carbohydrate analysis
For screening and sequencing of carbohydrates, recently,
a disposable polymer microchip with integrated micro-
channels and electrodes was coupled to both a quadru-
pole TOF (QTOF) and an FTICR mass spectrometer [27,
28].
The chip presented in Fig. 1 was microfabricated by
semiconductor techniques including photolithography
[29]. For the microchip fabrication, the starting material
was a polyimide foil of 75 mm thickness, which is coated
on both sides with 5 mm copper. A photoresist was pat-
terned on the copper-coated polyimide foil through a
printed slide acting as a mask. Photoresist was then
developed and chemical etching was used to remove the
deprotected copper where microchannels are to be pat-
terned. Polyimide was plasma-etched to the desired
depth. As both sides of the substrate were exposed to the
plasma, through-holes were fabricated to act as sample
reservoirs and/or provide access to the microchannel.
The final microchannels were 120 mm wide, 45 mm deep
(nearly “half moon” cross section), with 100 mm gold-
coated microelectrodes placed at the bottom of the
microchannel. A 35 mm polyethylene/polyethylene te-
rephthalate was laminated to close the channels. As
described by Gobry et al. [15], one end of each channel
was manually cut in a tip shape, so that the outlet of the
microchannel was located on the edge of the chip. For
sample dispensing, either a reservoir was pasted over the
inlet of the microchannel or the chip was sandwiched in a
home-made chip holder with an integrated reservoir. For
MS coupling one end of each channel was manually cut in
Figure 1. Schematic of the polymer chip holder with
integrated reservoir. (1) Polymer chip; (2) sandwich chip
holder; (3) sample reservoir; (4) conductive wire. Repro-
duced from [28]; with permission.
a tip shape, which was visually inspected with a stereo-
microscope. This way, the outlet of the microchannel is
located on the edge of the chip, providing an in-plane
electrospray.
The thin polymer chip was coupled to a QTOF-MS
(Micromass, UK) with Z-spray ion source geometry [27].
For sample loading, a microvial reservoir was pasted over
the inlet-hole of the microchannel and the whole chip/
reservoir assembly was mounted onto the mass spec-
trometer. An optimal coupling able to promote efficient
ionization and sensitive detection of carbohydrates was
found to require (i) stable electrical contact, (ii) careful
positioning of the chip toward the MS sampling cone,
(iii) adjustment of the ESI voltage and sampling cone
voltages within 2–3 kV and 80–100 V, respectively, and
(iv) systematic control of the solvent/analyte desolvation
process. In order to realize the electrical contact to the
ESI power supply, the ESI-QTOF sampler was removed
and the chip system was directly connected to the ESI
high-voltage plate, which is a fixed part of QTOF conven-
tional ESI source. Exchange between the original source
and chip system interface did not claim for any definitive
dismantling or special mechanical modifications to either
of the original assemblies and no further modifications on
the QTOF-MS were reported as necessary. The position
of chip emitter was adjusted in the vicinity of the entrance
hole at a distance of about 5 mm from the QTOF-MS
sampling cone. The ESI field was established by applying
a voltage (2–3 kV) on the microchip electrode and an
attractive potential (100–150 V) on the MS counter-
electrode (cone). The voltage on the microelectrode was
applied by using a conductive wire with one terminal
connected to the chip electrode and the other fixed on the
ESI high-voltage plate of the QTOF-MS instrument. Under
 2005 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
Electrophoresis 2005, 26, 3650–3673 Chip electrospray mass spectrometry of carbohydrates 3653
the formed high electric field, the fluid was electro-
kinetically driven through the chip microchannel from its
inlet-hole toward the outlet-edge where the electrospray
process occurred [27]. In the case of QTOF-MS, the ESI
source is configured in Z geometry by the orthogonal
alignment of the sampling capillary and MS counter-
electrode.
In Fig. 2, a photography of the QTOF source assembly with
mounted polymer chip is presented. The photography has
been taken during the thin chipESI-QTOF-MS running,
immediately after application of the negative voltages on
both chip and counterelectrode. The ESI plume is clearly
visible demonstrating the instant initiation of the electro-
spray. Under the same ESI-QTOF-MS conditions, the
reported [27] in-run reproducibility in terms of sensitivity,
spray stability, number of detected components/frag-
ments, ion intensity, and charge state was almost 100%,
while the day-to-day reproducibility was 95–100%.
The first interfacing of chip electrospray to FTICR-MS was
reported in 2003 by Rossier et al. [30]. The system
described by the authors included the thin polymer
microchip placed into a specially designed holder and a
7 T FTICR MS (Bruker Daltonics) operating in the positive
ion mode. In this study, the first application of the chip-
FTICR system to proteome analysis and in particular to
complex tryptic peptide mixture of the human micro-
tubule-associated tau protein, considered as a target in
neurofibrillary tangles characteristic of Alzheimer disease,
is described. In the (1)chipESI-FTICR mass spectrum the
primary structure including 18 serine (Ser) and threonine
(Thr) phosphorylations could be directly identified, which
clearly demonstrated the high analytical performance of
the chipESI-FTICR-MS in proteomics.
Figure 2. Photography of the thin polymer chip/ESI-
QTOF-MS coupling, taken immediately after the applica-
tion of the ESI voltages. Reproduced by permission of
The Royal Society of Chemistry [27].
Last year, an Apex II FTICR mass spectrometer equipped
with a 9.4 T superconducting actively shielded magnet
and an Apex II Apollo ESI ion source was interfaced to the
disposable thin polymer microchip, and the system was
for the first time optimized in the negative ion mode and
introduced in glycomics [28]. For sample loading and
FTICR interfacing, the chip was sandwiched in a home-
made chip holder with an integrated reservoir (Fig. 1) and
positioned into the holder with the microchannel in con-
tact with the reservoir and the front part extruding a few
millimeters. Unlike the case of ESI-QTOF source, in the
FTICR Apex II Apollo system the sampling capillary is
grounded and the electric field is created by applying the
ESI voltage on the MS metal-coated glass capillary.
Therefore, for polymer chip interfacing to FTICR-MS, the
chip was grounded via a conductive wire connected to
the terminal gold-coated electrode. Another peculiarity of
the FTICR ESI source is its direct spray geometry as a
result of axial alignment of the sampling capillary and MS
entrance. The microchip system was coupled to this ion
source by an in-laboratory constructed mounting system
consisting of a metal plate connected to the source by
two 907 brackets. The in-house made mounting system
was described as a robust and viable interfacing of the
polymer chip to the FTICR-MS instrument.
2.2 Applications
2.2.1 Complex biological mixtures of
glycopeptides
In human urine, carbohydrates are catabolic products
excreted as either oligosaccharides or glycopeptides and
their concentration, amount, and structure are known to
vary under different physiological and/or pathological
conditions. For this reason, monitoring the glycopeptide
expression in human urine by MS could potentially
become a method of diagnostic importance [31]. Various
glycoconjugate pools extracted and purified from normal
human urine and urine of patients suffering from diseases
caused by aberrant glycosylation were already submitted
to a number of MS-based analytical experiments to
assess their potential for glycoscreening [32–35].
The thin chip microsprayer/QTOF-MS coupling described
above was optimized in the negative ion mode for deter-
mination of O-GalNAc-Ser/Thr expression in the normal
human urine [27]. A mixture of O-GalNAc glycosylated
amino acids and peptides was dissolved in pure methanol
to a concentration of 5 pmol/mL and an aliquot of 10 mL
was dispensed into the reservoir pasted over the inlet of
the chip microchannel. The negative ion mode electro-
spray process was initiated at 2.8 kV ESI voltage and
100 V potential of the sampling cone. At these values of
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source parameters a constant and stable spray accom-
panied by a high intensity of the total ion current was
generated. The signal was acquired over 20 scans (40 s)
which, at the flow rate of about 200 nL/min provided by
the microchip under these conditions, was equivalent to a
sample consumption of 0.66 pmol. The spectrum com-
bined over 20 scans exhibited a high S/N and a number of
26different saccharide components. Fifteen species
detected as singly and/or doubly charged ions expressed
O-GalNAc-Ser/Thr core-motif extended by either sialyla-
tion or fucosylation. The mixture was found to be domi-
nated by Ser- and Thr-linked disialo saccharides with
chain lengths ranging from tetra- to octasaccharide.
Interestingly, two new structures which could originate
from glycopeptides with extended and further modified
chains, not detectable before by any MS-related meth-
ods, were detected as doubly charged ions.
In order to test the limit of the microchip sensitivity for
glycoconjugate detection, the solution was further diluted
in pure methanol yielding an aliquot at 1.25 pmol/mL con-
centration. The signal was acquired over 20 scans, which
was equivalent to 0.16 pmol sample consumption for this
experiment. Even under these restrictive concentration
conditions, a fair S/N was reported and 13different com-
ponents in the mixture could be still identified. All micro-
chip spectra exhibited an interesting peculiarity related to
ionic charge-state distribution. Thus, it was found that at
100 V cone potential, the charge distribution was not
shifted toward lower values as observed in the capillary-
based ESI-QTOF-MS experiments and the intensity of the
signals corresponding to the doubly charged ions was still
the highest ones. Moreover, the advantage of the micro-
chip ESI-MS regarding the minimization of the in-source
decay of the labile attachments such as N-acetyl neur-
aminic acid (Neu5Ac) was observed.
To investigate the possibility of rapid and accurate glyco-
peptide sequencing by MS/MS using the polymer chip for
sample infusion, a doubly charged ion at m/z 532.08,
assigned according to the m/z value to the already known
structure of NeuAc2HexHexNAc-Thr (Hex = hexose,
HexNAc = N-acetyl hexosamine), was isolated and sub-
mitted to low-energy CID (2)microchip ESI-QTOF-MS/
MS. Ion acceleration energy, collision gas pressure, and
precursor ion isolation parameters were carefully adjus-
ted to provide the full set of structural information upon
the molecule. The product ion spectrum (Fig. 3) was
obtained after 30 scans (1 min) of signal acquisition under
the sample consumption of 1.23 pmol. A high S/N and
significant number of diagnostic elements valuable for
assessing the sialylation pattern and linkages specific to
the core 1 type of O-glycosylated molecules were
obtained.
In another study, the combination of the thin chip micro-
sprayer performances with high accuracy and resolution
of the FTICR-MS was designed and implemented for the
screening in negative ion mode of several urine glyco-
Figure 3. Microchip ESI/QTOF
MS/MS of the Neu5Ac2Hex-
HexNAc-Ser doubly charged ion
at m/z 532.08. ESI voltage:
2.8 kV; sampling cone potential:
100 V; solvent: methanol; aver-
age sample concentration:
5 pmol/mL; collision energy:
40 eV; signal acquisition:
30 scans; average sample con-
sumption: 1.23 pmol. Nomen-
clature for assignment of frag-
ment ions is according to [61,
62]. Reproduced by permission
of The Royal Society of Chem-
istry [27].
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peptide mixtures [28]. Special considerations of the thin
chipESI/FTICR-MS parameters with respect to the direct
spray configuration of the FTICR instrument were neces-
sary here. The initiation of the electrospray was achieved
at 1500–2500 V applied to the transfer capillary, while the
fine positioning of the microsprayer toward the MS inlet
turned out to be crucial for efficient transfer of the ionic
species into the MS and long-term stability of the elec-
trospray. The system was tested for compositional map-
ping of a mixture of O-glycosylated amino acids and
peptides extracted and purified from urine of a patient
suffering from Schindler disease and an age-matched
healthy individual for comparative assay [28]. Schindler
disease is a rare inherited metabolic disorder character-
ized by a deficiency of the lysosomal enzyme a-N-ace-
tylgalactosaminidase (NAGA), which leads to an abnormal
accumulation of sialylated and asialo-glycopeptides and
oligosaccharides with a-N-acetylgalactosaminyl resi-
dues. The deficient NAGA is causing not only a 100 times
higher concentration of O-glycans in patient urine than in
healthy controls, but it was also found to give rise to
unspecifically cleaved products consisting of longer sac-
charide chains [31, 36–38].
In Fig. 4, the (2)thin chipESI/FTICR mass spectrum of the
O-glycosylated amino acids and peptides disease is
depicted. After 50 scans of signal recording under a flow
rate of approximately 200 nL/min, 27 ionic species could
be already identified and straightforwardly assigned with
an average mass accuracy of 5.41 ppm and a maximum
sensitivity of 3 pmol/mL (Fig. 4). In comparison with the
chipESI/FTICR spectrum of the normal urine glycopep-
tides, a higher content of pentasaccharides was
observed, as documented by the doubly charged ion at
m/z 562.193 and the corresponding singly charged ion at
m/z 1125.386, assigned to Neu5AcHex2HexNAc2-Ser.
The doubly charged ion at m/z 569.199 along with its sin-
gly charged counterpart at m/z 1139.401 was assigned to
the homologous structure, Neu5AcHex2HexNAc2-Thr.
Additionally, the hexasaccharides linked to Ser and Thr
bearing two sialic acid moieties were detected at higher
abundance than in the glycopeptide mixture from normal
urine, and a nonasaccharide bearing three sialic acid
moieties was for the first time detected at appreciable
abundance as a doubly charged ion at m/z 1058.354 and
assigned to the sodiated dehydrated Neu5Ac3Hex2Hex-
NAc4Ser with a mass accuracy of 4.6 ppm.
Figure 4. (2)Microchip ESI/FTICR MS of a fraction of O-glycosylated peptides extracted from urine
of a patient diagnosed with Schindler disease. ESI voltage: 1.5–2.5 kV. Capillary exit: –79 V. Average
sample concentration: 20 pmol/mL in methanol. Number of scans: 50. Average sample consumption:
2 pmol. Inset: table with assignment of the ions detected in the mixture by microchip ESI/FTICR-MS
in the negative ion mode. Reproduced and adapted with permission from [28].
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2.2.2 Gangliosides
Gangliosides are glycosphingolipids (GSLs) consisting
of a mono- to polysialylated oligosaccharide chain of
different lengths attached to a ceramide portion of vari-
able composition with respect to the type of sphingoid
base and fatty acid residues. They are abundant com-
ponents of the central nervous system and their com-
positions undergo changes during brain development,
maturation, aging, and neurodegeneration processes
[39–41]. For these reasons, gangliosides are considered
as tissue stage or diagnostic markers and potentially
therapeutic agents. In human brain, region-specific dif-
ferences in ganglioside composition and quantity, as
well as in their distribution and expression have been
demonstrated primarily by TLC, immunochemical, and
immunohistochemical methods besides FAB-MS [42,
43] and capillary-based electrospray [44]. In all ESI-MS-
related studies using either QTOF-MS [44], off-line CE/
QTOF-MS, or FTICR-MS [45, 46], requirements for ele-
vated values of ionization parameters and an extended
time for CID-MS/MS signal acquisition, implying more
sample consumption for identification and structural
elucidation, were defined.
To explore the performance of the microchip ESI/QTOF-
MS approach and the detection limits for structural char-
acterization of gangliosides, a fraction of polysialylated
gangliosides (GT1), isolated from the total native ganglio-
side mixture of normal adult human brain, was considered.
For (2)microchip ESI/QTOF-MS analysis, GT1 sample was
dissolved in pure methanol to a concentration of 5 pmol/mL
and an aliquot of 10 mL was loaded into the microchip
reservoir. To optimize the ionic current value, the (2)ESI
voltage and cone potential were increased following a
ramping procedure. The total ion chromatogram (TIC) pro-
file indicated a maximum of ionic current, a sustained
spray, and an efficient ionization at 3 kV ESI and 100 V
sampling cone voltages. After 4 min of signal acquisition at
a flow rate of 200 nL/min a spectrum of high S/N was
obtained (Fig. 5), although a fair S/N was observed already
after 60scans (30 s). A reproducible compositional map-
ping of eight GT1 molecular components, reflecting differ-
ent lipid variants in the fraction, was obtained from both
triply and doubly charged molecular ions. Interestingly,
three minor GT1 molecular species not detectable by
capillary infusion could be documented by the low-abun-
dant molecular ions atm/z 1094.20, 1108.20, and 1109.21,
assigned by calculation to GT1 (d18:1/21:1), GT1 (d18:1/
23:1), and GT1 (d18:1/23:0), respectively.
In the same study [27], the thin chipESI/QTOF-MS was
explored to address the fundamental issue of efficient
fragmentation analysis by CID-MS/MS of ganglioside
species, known to require an extended signal acquisition
time under variable collision energies to generate enough
Figure 5. Microchip ESI/QTOF
MS1 of a ganglioside fraction
derived by combining the TIC
MS scans at 3 kV ESI voltage
and 100 V sampling cone
potential. (a) m/z range: (650–
1175). Inset: the compositional
mapping of the purified native
GT1 ganglioside fraction (exhib-
iting HPTLC migration proper-
ties of the GT1b species) sepa-
rated from the total ganglioside
mixture isolated from adult hu-
man brain tissue as detected by
(2)microchip ESI-QTOF-MS1.
Reproduced and adapted by
permission of The Royal Society
of Chemistry [27].
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fragment ions for high sequence coverage. By this novel
approach, the instability of the electrospray and/or signal
interruption, frequently reported in the case of capillary-
based ESI [44], could be overcome, and a stable TIC
MS/MS was shown to be crucial for different sequencing
events. A triply charged ion at m/z 717.50, corresponding
to the GT1 (d18:1/20:0), could be successfully sequenced
(Fig. 6). The fragmentation process gave rise to sialylated
fragment ions indicative for the carbohydrate sequence of
the GT1, as well as for characterization of its ceramide
portion. The complete fragmentation pattern of the mole-
cule (Fig. 7) could be deduced from the abundant Y- and
Z-type ions formed from the nonreducing end, while the
X-type ring cleavages appeared at lower abundance.
Informative C- and B-type ions observed to be similarly
favored under given conditions were obtained. Moreover,
a number of fragment ions deriving from different sugar
portion GT1 isomers, in particular m/z 364.09 (B2a),
966.39 2,4X2a specific for GT1c, and m/z 493.10 (B2a/B1a)
specific for GTa, respectively, could be clearly dis-
criminated here, supporting the presence of structural
isomers or isobars as distinct species.
3 Fully automated chip-based electrospray
MS
3.1 Coupling of the fully automated chip-based
nanoESI system to high-performance MS
for carbohydrate analysis
NanoMate 100 (Advion BioSciences), the world’s first
fully automated nanoelectrospray system, is a robotic
device that provides an automated nanoelectrospray ion
source for mass spectrometers [8]. In this system, by an
automatic infusion, samples at low flow rates (50–100 nL/
min) are admitted directly into MS [9, 10]. In addition to
the robot itself, the key component of the system is the
ESI chip. The robot holds a 96-well sample plate and a
96-pipette tip tray. Automated sample analysis is
achieved by loading a disposable, conductive pipette tip
on a movable sampling probe, aspirating sample via a
syringe pump, and moving the sampling probe to engage
against the back of the ESI chip. ESI process is initiated
by applying a head pressure and voltage to the sample in
the pipette tip. Each nozzle and tip is used only once in
Figure 6. Microchip ESI/QTOF-MS/MS of the triply charged ion at m/z 717.50 corresponding to GT1
(d18:1/20:0). ESI voltage: 3 kV. Sampling cone potential: 100 V. Spectrum is derived by combining the
scans corresponding to 40 and 70 eV in the TIC MS/MS. Nomenclature for assignment of fragment
ions is according to [63–65]. Reproduced by permission of The Royal Society of Chemistry [27].
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Figure 7. Structure and the corresponding fragmentation scheme of the GT1b species. Product ions
detected from the spectrum depicted in Fig. 6 are assigned. Nomenclature for assignment of frag-
ment ions is according to [61–65]. Reproduced by permission of The Royal Society of Chemistry [27].
order to eliminate carryover and contamination typical to
conventional autosamplers. The ESI chip is an array of
nanoESI nozzles of 10 mm internal diameter etched in a
planar silicon chip. The chip is fabricated from a mono-
lithic silicon substrate using deep reactive ion etching
(DRIE) and other standard microfabrication techniques
[7]. The inert coating on the surface allows a variety of
acidic and organic compositions and concentrations to
be used to promote ionization without any degradation of
the nozzle [7]. As visible in Fig. 8, a channel extends from
the nozzle through the microchip.
In conventional electrospray devices the electric field is
defined by the potential difference between the ESI tip
(fluid potential) and the mass spectrometer inlet. A unique
feature of the ESI chip is the incorporation of the ESI
ground potential into the spray nozzle so that the electric
field around the nozzle tip is formed from the potential
difference between the conductive silicon substrate and
the voltage applied to the fluid via the conductive pipette
tip [7–11]. In such a configuration, the distance that
Figure 8. NanoMate 100 incorporating ESI chip tech-
nology. Courtesy of Advion BioSciences.
defines the electric field is about 1000 times shorter than
the one between the nozzle and mass spectrometer.
Therefore, the mass spectrometer position and voltage,
though crucial for efficient ion transfer into analyzer, do
not play any role in formation of the chip electrospray,
thus essentially decoupling the ESI process from the inlet
of the mass spectrometer.
For carbohydrate analysis, the NanoMate robot was first
mounted onto the QTOF and IT mass spectrometers [47–
49] via special brackets, allowing adjustment of the robot
position with respect to the sampling cone. Recently, the
first coupling of the NanoMate robot to the FTICR-MS at
9.4 T and sustained off-resonance CID (SORI CID) MS/
MS was reported [50]. The new assembly was optimized
in the negative ion mode to combine automated sample
delivery on the chip along with maximal sensitivity, ultra-
high-resolution, accurate mass determination provided
by the FTICR instrument, and efficient MS/MS in one
system. In this study a specially designed interface was
constructed by Bruker Daltonik (Bremen, Germany) in
order to obtain a viable coupling of the NanoMate system
to the Bruker Apex II Apollo ion source. An interesting
coupling feature derived from the NanoMate ionization
principle was the possibility to initiate and maintain a
constant electrospray under a very low, if any, voltage on
the metal-coated glass capillary of the FTICR instrument.
3.2 Applications
3.2.1 Complex biological mixtures of
glycopeptides
The feasibility and analytical potential of the fully auto-
mated chip-based ESI/QTOF-MS for high-performance
glycoscreening, sequencing, and identification was for
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the first time explored on a complex glycopeptide mixture
of O-glycosylated sialylated amino acids and peptides
obtained from urine of a patient suffering from Schindler
disease [48]. Using the negative ion mode detection and
methanol as a solvent, the NanoMate provided a sample
infusion at 100 nL/min flow rate. For a sample concentra-
tion of approximately 2–3 pmol/mL, spectra of high S/N
were obtained within less than 1 min of acquisition, indi-
cating a two to three times higher sensitivity than the one
obtained in a similar study by using the conventional
capillary-based nanoESI in Z-spray geometry (unpub-
lished results).
The reduced S/N of low-abundant molecular precursor
ions in complex mixtures obtained by classical nanoESI-
MS/MS can generally be overcome by extended accu-
mulation in an off-line approach [44], but it is frequently
hindered by spray and/or signal instability. The perfor-
mance of the NanoMate system to provide long-lasting
electrospray signal, rendered reliable conditions for high
sensitivity, particularly useful for detection and sequenc-
ing of minor glycopeptide components, previously
accessible for fragmentation from such complex mixtures
only by the on-line CE/ESI-QTOF-MS [33].
Singly and doubly charged ions derived from tri- to
octasaccharide peptides or free oligosaccharides were
detected, originating from tri- (singly charged), tetra-
(singly and doubly charged), penta- (doubly charged),
and hexasaccharide (doubly charged) O-linked either to
Ser or Thr, whereas species from hepta- and octa-
saccharide peptides were observed as less abundant
doubly charged pseudomolecular ions. A large number
of minor sialylated oligosaccharide components were
identified as well. A low-abundant doubly charged ion
detected at m/z 890.32 in MS1 was subjected to the
chip nanoESI-MS/MS by CID at low collision energies
(Fig. 9) and, accordingly, the fragmentation pattern
(Fig. 10) could be identified and assigned to the octa-
saccharide Neu5Ac2Gal32GalNAc-Ser. All these data
demonstrated for the first time the ability of the Nano-
Mate chipESI/QTOF-MS methodology to identify minor
glycoconjugate species, or those having labile attach-
ments like sialic acid previously undetectable by ESI–
MS only [33].
The off-line CE-MS method is considered in some cases a
convenient approach due to its higher flexibility toward
system optimization than the one provided by the on-line
Figure 9. Automated chip-based (2)nanoESI/QTOF-MS/MS of Neu5Ac2Gal3GlcNAc2GalNAc-Ser
detected as a doubly charged ion at m/z 890.32. Spectrum is the sum of scans at collision energy 40
and 70 eV. Number of scans: 200. Average sample concentration: 3 pmol/mL. Average sample con-
sumption for the MS/MS experiment: 2 pmol. Nomenclature for assignment of fragment ions is
according to [61, 62]. Reprinted from [47], with permission.
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Figure 10. Fragmentation
scheme of Neu5Ac2Gal3Glc-
NAc2GalNAc-Ser detected as a
doubly charged ion at m/z
890.31. Reprinted with permis-
sion from [47].
methods. For this reason, the off-line coupling of CE to
(2)nanoESI-QTOF-MS has been lately intensively devel-
oped and implemented for glycoconjugate analysis. Its
potential for separation, screening, and structural eluci-
dation of different types of glycoconjugates, such as gly-
cosaminoglycans [51, 52], O-glycosylated peptides [53],
and gangliosides [54], was demonstrated in detail. How-
ever, using the CE instrument as a fraction collector, the
sample concentration is lowered because sample reser-
voirs contain electrolyte, so that volumes of a few nano-
liters are diluted into tens-of-microliters. Lack of sensitiv-
ity is therefore a major drawback of this approach.
The second limitation of the off-line approach is the low
throughput, as a consequence of both the time-consum-
ing collection of fraction and the additional treatments of
the sample sometimes necessary to be applied prior to
MS. Among the postseparation treatments, increasing
the sample concentration by solvent evaporation is the
most frequent and time-consuming one. These two
inherent problems associated to the off-line CE-MS cou-
pling could be to a significant extent overcome by auto-
mated chip-based negative ion ESI-QTOF-MS in off-line
conjunction with CE [55]. In this study, for testing the
compatibility of the off-line CE coupling to the (2)nano
ESIchip NanoMate/QTOF-MS for ionization and detec-
tion in a given CE buffer system, a multicomponent mix-
ture of O-glycosylated amino acids and peptides from
urine of patients suffering from Schindler disease was
dissolved in 0.1 M formic acid/ammonia pH 2.8 to a con-
centration of 5 pmol/mL and infused automatically into
MS. A constant and stable spray over 10 min analysis
time and high ionic current indicated the compatibility of
this buffer system with automatic chip-based ESI and that
the analyte molecules could be efficiently ionized. In
addition, the flow rate under these buffer conditions was
found reduced to 75 nL/min. Following the CE-UV analy-
sis in the reverse polarity, CE fractions were collected,
loaded onto the 96-well plate of the robot, and auto-
matically subjected to the (2)nanoESIchip NanoMate/
QTOF-MS and MS/MS (Fig. 11) without the need of pre-
concentration or any other postseparation treatment
which would significantly increase the experiment time.
Two major doubly charged ions at m/z 525.28 and 532.29
accompanied by their respective singly charged counter-
parts at m/z 1051.23 and 1065.23 corresponding to Ser-
and Thr-linked Neu5Ac2HexHexNAc (HexNAc = N-acetyl
hexosamine) have been separated and detected in the
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Figure 11. (2)NanoESIchip/QTOF mass spectrum of the second CE-collected fraction at 80 min
after injection. Solvent: 0.1 M formic acid buffered with ammonia to pH 2.8; fraction/buffer con-
centration: ,3 pmol/mL. Number of scans: 100. Average sample consumption for MS experiment:
0.4 pmol. Copyright  2004 John Wiley & Sons. Reproduced with permission from [55].
second CE fraction. Ser- and Thr-linked Neu5AcHex-
HexNAc were also observed as singly charged ions at m/
z 760.24 and 774.28, respectively. In lower abundance,
the Ser-linked Neu5Ac2Hex2HexNAc2 was detected as a
doubly charged ion at m/z 707.75. Although previously
[53] the off-line CE/MS was reported to require rather
high amounts of glycopeptide sample for detection, the
final concentration of the fraction was here approxi-
mately 3 pmol/mL. In the case of ammonium formate, the
75 nL/min flow rate exhibited by the NanoMate chip
system yielded a fair S/N by only 30 scans of signal
accumulation (Fig. 11) under the sample consumption of
approximately 0.4 pmol, which is a superior sensitivity in
comparison with the capillary-based experiments [53,
54]. Due to the high spray stability, the MS/MS investi-
gation of a low abundant doubly charged ion at m/z
707.75 attributed to Neu5Ac2Hex2HexNAc2-Ser was
greatly enhanced (Fig. 12). The low signal intensity cor-
responding to this ion could be compensated by the
longer acquisition time (15 min) of the MS/MS signal. By
this procedure, a sufficient number of sequence ions for
clear-cut structural elucidation of the molecule could be
generated and detected (Fig. 13). It is noteworthy to
mention that in this study, the total amount of sample
consumed for generating one MS and three MS/MS of
high S/N and sufficiently informative was only 12 pmol.
In another study, the newly conceived NanoMate/FTICR
coupling was tested for screening and sequencing by
sustained off-resonance (SORI)-CID of O-glycosylated
peptides and amino acids extracted from urine of a
patient suffering from Schindler disease and from urine of
a healthy age-matched individual for comparative analy-
ses [50]. The mixtures were dissolved in methanol to dif-
ferent concentrations and transferred onto the glass
microtiter plate of the NanoMate robot. The highest sen-
sitivity obtained in this set of experiments was 0.5 pmol/
mL, which represents a value with one order of magnitude
higher than the one achieved in a similar study carried out
by using capillary ESI infusion in the same Apollo Apex II
configuration [32]. For the initiation of the chip spray, the
fine tuning on the x-, y-, and z-axes of the chip nozzle to-
ward the FTICR-MS inlet has been reported to be a critical
step [50]. In addition, it was shown that a significant
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Figure 12. (2)NanoESIchip/QTOF-MS/MS of the doubly charged ion at m/z 707.75 assigned to
Neu5Ac2Hex2HexNAc2-Ser detected in the second CE-collected fraction. Collision energy: 20–40 eV;
collision gas pressure: 12 psi. For precursor ion isolation, LM (low-mass resolution) and HM (high-
mas resolution) parameters were set at 10 and 10, respectively. Number of scans: 400. Average
sample consumption for MS/MS experiment: 3 pmol. Nomenclature for assignment of fragment ions
is according to [61, 62]. Reproduced from [55], with permission.
Figure 13. Fragmentation
scheme of the doubly charged
ion at m/z 707.75 assigned to
Neu5Ac2Hex2HexNAc2-Ser de-
tected in the second CE-col-
lected fraction. Nomenclature
for assignment of fragment ions
is according to [61, 62]. Repro-
duced from [55], with permis-
sion.
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increase of the spray stability and intensity of the MS sig-
nal could be achieved by applying a low potential of 50 V
to the ion transfer capillary of the FTICR-MS instrument.
In Fig. 14, the (2)chipESI/FTICR-MS of an O-glycopep-
tide mixture from patient’s urine is depicted, where a sig-
nificantly higher number (50) of components than pre-
viously detected [32] was found. These glycoforms were
in general Ser- and Thr-linked disialo saccharides
expressing various saccharide chain lengths ranging from
tetra- to octasaccharide. MS experiments carried out
under the same conditions of sample solution and ioni-
zation/detection indicated a run-to-run and nozzle-to-
nozzle reproducibility of nearly 100%. The particular ad-
vantage of the NanoMate system to exhibit a high ioniza-
tion yield and a preferential formation of multiply charged
ions is clearly illustrated by the spectrum in Fig. 14. In
comparison with previously reported data obtained by
regular capillary-based (2)nanoESI-FTICR-MS on a simi-
lar glycopeptide mixture [32], the (2)nanoESIchip/FTICR-
MS was found to provide a higher ionization efficiency of
even less abundant glycopeptide species. In addition, by
(2)nanoESIchip/FTICR-MS a considerable number of
triply charged ions could be formed and detected under a
high S/N, whereas by capillary-based (2)nanoESI-FTICR-
MS no triply charged glycopeptide ions were formed/
detected [32].
Moreover, four new components, not identified by any
other method before [32–35], were detected by this novel
approach and identified under a high mass accuracy: to
sodiated Ser- and Thr-linked (disialo) octasaccharides
and (trisialo) undecasaccharides, respectively (Fig. 14).
For identification of potential diagnostic marker compo-
nents, a mixture of O-glycopeptides extracted from urine
of an age-matched healthy control person, identically
prepared as described before, was subjected to (2)ESI-
chipNanoMate/FTICR-MS and SORI-CID MS/MS under
the same experimental conditions as those from patient
urine [50]. The MS pattern was different: in this mixture a
reduced number of glycoconjugate species has been
found, where those with shorter chains and lower degree
of sialylation were dominating. By the NanoMate/FTICR
SORI-CID MS/MS experiment, the structure of the Ser-
linked (disialo) hexasaccharide components could be
straightforwardly determined.
Figure 14. Automated (2)chipESI/FTICR mass spectrum of a fraction from urine of patients suffering
from Schindler disease. Apex II metal-coated glass capillary voltage: 50 V. Capillary exit: 279 V.
Sample concentration: 5 pmol/mL in methanol. Number of scans: 150. Average sample consumption
for MS experiment: 2.5 pmol. Inset: Table: Ions detected and identified with a mass accuracy below
12 ppm in the mixture of O-glycosylated peptides at 5 pmol/mL. Nomenclature for assignment of
fragment ions is according to [61, 62]. Reproduced and adapted with permission from [50].
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3.2.2 Combination of fully automated
chip ESI-MS and automated software
assignment for identification of
heterogeneous mixtures of N-,
O-glycopeptides, and oligosaccharides
A urine fraction containing sialylated carbohydrates from a
patient presenting a clinical picture associated congenital
disorders of glycosylation (CDG) was submitted to glyco-
screening by fully automated chip-based (2)nanoESI/
QTOF-MS [47]. The sample with average concentration of
5 pmol/mL in methanol was loaded onto the 96-well plate
of the NanoMate robot. Following automatic infusion, the
mass spectrum acquired for 3 min displayed a high level of
heterogeneity concerning the type of glycans and glyco-
peptides, as well as the degree of sialylation (Fig. 15). For
preliminary analysis and assignment of glycoforms, a
computer algorithm for calculation of glycoconjugate
composition was developed [47, 56] thus providing the first
two-stages platform for completely automatic and high-
throughput analysis: (1) robotized sample delivery and
infusion into MS followed by (2) automatic identification of
components using software-assisted assignment. The
experimental data for the input were them/z values and the
respective charge states provided by chip MS and MS/MS
experiments. The capacity of the computer program was
to calculate and propose all possible structures containing
hexose (Hex), HexNAc, deoxyhexose (dHex), and Neu5Ac
as monosaccharide building-block units. In the second
step, the modeling of the theoretical fragmentation pattern
from different structures with the same m/z was pro-
cessed. The data were presented as a combination of ions
B, C, Y, and Z, related to the cleavage of glycosidic bonds,
as well as the A- and X-ring cleavage ions, aligned to the
proposed structure of the chosen molecular ion. In Table 1
the software first-step MS analysis along with the pro-
posed composition of single components from the chip-
based (2)nanoESI/QTOF spectrum presented in Fig. 15 is
given. The most prominent structures in the mixture were
directly identified by this approach.
As an example, the doubly charged molecular ion at
m/z 1008.74 (Fig. 15) showing the composition of either
Neu5Ac2Hex5HexNAc3 or Neu5Ac2Hex3HexNAc1dHex5
was submitted to the automated chip-based (2)nanoESI/
QTOF-MS/MS by CID at low energies. The fragment ions
of Neu5AcHex, Neu5AcHexHexNAc, Neu5AcHex2Hex-
NAc, and Neu5Ac2Hex5HexNAc2 as C2, C3, C4, and C5
were assigned by this software to a truncated N-linked
biantennary glycan missing the terminal HexNAc at the
reducing terminus.
Figure 15. Fully automated chip-based (2)nanoESI/QTOF MS of the mixture containing glycans and
glycopeptides from urine of a patient diagnosed with CDG. Average sample concentration: 5 pmol/
mL; number of scans: 100. Average sample consumption for MS experiment: 2 pmol. Sampling cone
potential: 50 V. Reprinted from [47], with permission.
 2005 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
Electrophoresis 2005, 26, 3650–3673 Chip electrospray mass spectrometry of carbohydrates 3665
Table 1. Computer-assisted assignment of the major ions detected by automated chip-based
(2)nanoESI/QTOF-MS in the mixture of glycans and glycopeptides from urine of a patient
diagnosed with CDG.
[M 2 2H]22m/z [M 2 H]2m/z Composition according to calculation Theoretical m/z
290.10 NeuAc (–H2O) 290.09
308.10 NeuAc 308.10
461.14 NeuAc2Hex2 461.15
470.15 NeuAcHex 470.15
481.65 NeuAc2HexHexNAc 481.66
493.15 NeuAcHexNAc (–H2O) 493.17
525.16 NeuAc2HexHexNAc-Ser 525.18
532.15 NeuAc2HexHexNAc-Thr 532.18
583.18 NeuAc2HexHexNAc2 583.20
656.18 NeuAc2dHexHexHexNAc2 656.23
664.19 NeuAc2Hex2HexNAc2 664.23
673.19 NeuAcHexHexNAc 673.23
707.72 NeuAc2Hex2HexNAc2-Ser 707.74
718.68 NeuAc2Hex2HexNAc2-Ser (Na) 718.74
826.21 NeuAc2Hex4HexNAc2 826.28
846.73 NeuAc2Hex3HexNAc3 846.80
899.24 NeuAc2dHexHex4HexNAc2 899.31
964.26 NeuAc2HexHexNAc 964.33
986.23 NeuAc2HexHexNAc (Na) 986.33
1008.74 NeuAc2Hex5HexNAc3 1008.84
1037.72 NeuAcdHexHex5HexNAc4 1037.87
1110.30 NeuAc2Hex5HexNAc4 1110.38
1139.26 NeuAcdHexHex5HexNAc5 1139.41
1175.28 NeuAc2HexHexNAc-Ser (2Na 1 P) 1175.32
1183.30 NeuAc2dHexHex5HexNAc4 1183.41
1212.26 NeuAcdHex2Hex5HexNAc5 1212.43
Reprinted from [47], with permission.
3.2.3 Characterization of N-glycosylation
microheterogeneity and sites in intact
glycoproteins
Glycosylation of proteins is one of the most ubiquitous
post-translational modification. It is highly regulated and
changes during differentiation, development, under dif-
ferent physiological and cell culture conditions, and in
disease.
Diversity of glycoprotein structure resides on number and
position of glycosylation sites within the polypeptide
backbone and the type of sugar attached. Besides the
microheterogeneity on the same glycosylation site, a
number and type of glycan chain phosphorylation, sulfa-
tion, methylation, and acetylation may be found on glycan
residues [57–59]. Therefore, a demand for a complete
analysis of a single glycoprotein would have to provide
information regarding microheterogeneity at single gly-
cosylation sites as well as a structural characterization of
the appropriate carbohydrate moiety.
Due to recent advances in automated chipESI-MS and
the development of small-scale sample preparation pro-
cedures, the characterization of glycosylations became
amenable to high-throughput experiments, in which the
necessary sample amount was decreased to the low
picomolar level. In the first study carried out for the
determination of the glycosylation site by fully automated
chip nanoESI-MS, the NanoMate 100 robot was coupled
to the front of a Finnigan LTQ IT via a specially designed
mounting bracket [49]. The tryptic digest of bovine pan-
creatic ribonuclease B was dissolved in 50% methanol
with 0.1% formic acid for positive ion mode and in
50% methanol with 0.1% ammonium hydroxide for
negative ion mode to the concentration of 1 pmol/mL. Five
microliters of sample was loaded onto the 96-well plate of
the robot and infused into the LTQ IT MS at a flow rate of
100 nL/min. From the full-scan MS the complex peptide
mass fingerprint of ribonuclease B was derived. Several
peptides were sequenced by MS/MS using collision
energies of 20–25% and a maximum scan time of 50 ms
in combination with the automated search program Bio-
 2005 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
3666 A. D. Zamfir et al. Electrophoresis 2005, 26, 3650–3673
Works 3.1 (Finnigan LCQ). Nine out of 14possible tryptic
peptides were identified, resulting in a protein sequence
coverage of 87%. The unidentified ions, showing a pat-
tern typical for high-mannose type of glycosylation, were
subjected to multiple stage MS, up to MS5. As shown in
Fig. 16a by fully automated chip-based infusion in com-
bination with multiple stage CID MS, spectra of high
quality and rich in information related to protein glycosy-
lation could be obtained. Since the N-glycopeptides tend
to fragment mostly at their oligosaccharide portion, it is
often difficult to gather the data necessary for the char-
acterization of their amino acid sequence. In the case
described here the amino acid sequence was obtained in
the MS4 experiment as illustrated in Fig. 16b.
Fully automated chip-based nanoESI coupled to Q-
FTICR at 9.4 T was recently employed for the first direct
identification of multiple O-glycosylation sites in hinge
region (HR) of immunoglobulin A1 (IgA1) isolated from
myeloma as reported by Renfrow et al. [60]. The method
was designed to provide heterogeneity assay of the tryp-
tic glycopeptide expressing various O-glycoforms and
particularly detection and localization of the Gal-deficient
IgA1 extracted, separated, and purified from myeloma
IgA1 HR and the structural elucidation of the glycopep-
tides by means of electron capture dissociation (ECD)-,
infrared multiphoton dissociation (IRMPD)-, and activated
ion ECD (AI-ECD)-MS/MS. The optimization of the meth-
odology in terms of sequencing analysis has been carried
out on a mixture of synthetically obtained peptides and
glycopeptides of the IgA1 HR type. The samples were
prepared at a concentration of 5 mM in 1:1 water/metha-
nol, 2% acetic acid and microelectrosprayed from an in-
house made fused silica capillary at a flow rate of 300 nL/
min. By employing IRMPD-MS/MS the assay of the pep-
tide sequence could be achieved, while by ECD-MS/MS
the glycosylation sites of single glycopeptide and/or mix-
ture of glycosylated peptides was unambiguously deter-
mined. For the tryptic-isolated myeloma IgA1 HR glyco-
peptides, the samples were desalted by C18 ZipTip into
30 mL of a 4:1 ACN/water solution containing 0.1% formic
acid, and submitted to microelectrospray and automated
chip-based ESI-FTICR-MS and MS/MS. The (1)ESI-
FTICR-MS of isolated IgA1 HR peptide features a series
of triply charged ions separated by one-third of the mas-
ses of GalNAc and Gal units. This reveals on one hand the
high heterogeneity of the differentially glycosylated spe-
cies, and on the other hand it can be deduced that the in-
source fragmentation is reduced almost to zero, since no
ion corresponding to nonglycosylated species could be
detected and identified. Based on the amino acid
sequence of the isolated IgA1 HR determined by IRMPD-
MS/MS, building-block analysis of the monosaccharide
units, and high mass accuracy and resolution of the
detection, the number of GalNAc and Gal residues
attached to the peptide back bone could be predicted.
This assessment indicated that two of the predicted gly-
copeptides could bear a Gal-deficient glycan part.
When applying the same sequencing protocol as for syn-
thetic peptides and glycopeptides for analysis of the iso-
lated IgA1 glycopeptides by IRMPD- and ECD-MS/MS,
only a limited number of fragment ions could be gener-
ated. Therefore, a combined sequencing technique
based on tandem IRMPD and ECD events, called AI-
ECD, was optimized to provide the full set of diagnostic
ions for the localization of glycosylation sites. Thus, the
quadrupole and stored waveform inverse Fourier trans-
form (SWIFT) isolated precursor ions were subjected for
300 ms to photon irradiation at 6.4 or 8 W laser power,
followed immediately by electron irradiation event for 10–
20 ms at cathode heating power of 11 W, which corre-
sponds to an electron emission current of 300 nA. The AI-
ECD FTICR MS/MS of an isolated [V216–L246] containing
four GalNAc and four Gal moieties, acquired under the
optimized sequencing conditions, gave rise to unambig-
uous determination of the glycosylation sites of the di-
saccharide units GalNAc-Gal to T225, T228, S230, S232,
respectively (Fig. 17). Based on the accurate ESI-FTICR-
MS1 mass determination, two of the glycopeptides were
predicted as Gal-deficient glycopeptides. The AI-ECD
FTICR-MS/MS of the [V216–L246] containing four GalNAc
and three Gal residues, predicted within a mass accuracy
of 3.6 ppm, is presented in Fig. 18. The product ions
generated by the peptide bone cleavage uniquely localize
three GalNAc-Gal residues at T225, T228, and S230, and a
GalNAc at S232 (Fig. 18).
3.2.4 Complex ganglioside mixtures
A recent study [48] was designed to assess the potential
of the fully automated (2)nanoESIchip/QTOF-MS and
automatic MS/MS for screening and sequencing of
gangliosides extracted from normal human cerebellar
gray matter. The highly complex ganglioside sample dis-
solved in 100% methanol was automatically infused
under the premise of optimization of the ESI chip ioniza-
tion yield for all single ganglioside components first at
higher concentrations (15 pmol/mL) and elevated values
of the ESI chip and sampling cone potentials. Such an
approach has been already demonstrated [42, 44] to
enhance the ionization yield of larger ganglioside species
from human brain tissues. Under these solution and
instrumental parameters major ganglioside variants were
detected, but minor components and/or longer chains,
assumed to be present in the mixture could, however, not
be found. The conditions were further modified by diluting
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Figure 16. (a) Fully automated
nanoESINanoMate/IT MS5 for
the stepwise removal of the
mannose residue from the pre-
cursor ribonuclease B N-glyco-
peptide. (b) Fully automated
nanoESINanoMate/IT MS4
derived from ribonuclease B
related N-glycopeptide for the
identification of amino acid
sequence. Inset: amino acid
sequence and predicted pep-
tides from tryptic digestion of
ribonuclease B. Nomenclature
for assignment of fragment ions
is according to [66]. Reprinted
and adapted with permission
from [49].
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Figure 17. (1)ESI/AI-ECD FTICR-
MS/MS spectrum of a popula-
tion of [216VTVPCOVPSTP-
PTPSPSTPPTPSPSCCHPRL 246
1 4GalNAc1 4Gal1 3H]31 ions
from the O-glycosylated IgA1
HR peptide. Isolation of the pre-
cursor ions: by quadrupole and
SWIFT. IRMPD event: 300 ms
photon irradiation at 6.4 or 8 W
laser power. ECD event: 10–
20 ms electron irradiation event
at 11 W cathode heating power,
,300 nA. Nomenclature for
assignment of fragment ions is
according to [66]. Reprinted by
permission of The American
Society for Biochemistry and
Molecular Biology from [60].
Figure 18. (1)ESI/AI-ECDFTICR-
MS/MS spectrum of a popula-
tion of [216VTVPCOVPSTP-
PTPSPSTPPTPSPSCCHPRL 246
1 4GalNAc1 3Gal1 3H]31 ions
from the O-glycosylated IgA1
HR peptide. Isolation of the pre-
cursor ions: by quadrupole and
SWIFT. IRMPD event: 300 ms
photon irradiation at 6.4 or 8 W
laser power. ECD event: 10–
20 ms electron irradiation event
at 11 W cathode heating power,
,300 nA. Reprinted by permis-
sion of The American Society for
Biochemistry and Molecular Bi-
ology from [60].
the sample to 2–3 pmol/mL and varying the cone potential
values from 45 to 135 V and the ESI capillary potential
from 1.45 to 1.67 kV (Fig. 19), which allowed high ioniza-
tion yield and detection of an extended number of spe-
cies. By this approach, a realistic representation upon the
ganglioside mixture heterogeneity as compared to data
provided by TLC analysis was reported. According to this
set of data, it was concluded that by ESIchip/MS a high
sensitivity for the analysis of ganglioside multicomponent
mixture, without compromising the ionization of minor,
biologically relevant components can be achieved.
Moreover, in this work the capability of the NanoMate
chipESI to minimize in-source fragmentation and signifi-
cantly reduce the analysis time as compared to ganglio-
side MS screening by capillary Z-spray sample infusion
[42, 44] was demonstrated.
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Figure 19. Fully automated (2)nanoESIchip/QTOF-MS of the native ganglioside mixture from normal human cerebellar
gray matter. Sample concentration: 2–3 pmol/mL in methanol; acquisition time: 3 min; number of scans: 90. Average sam-
ple consumption for MS experiment: 0.7 pmol, sampling cone potential: 45–135 V. n.a. = not assigned. (a) m/z (700–980).
(b) (980–2050). Reprinted and adapted by permission of Elsevier [48].
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In Table 2, the assignment of singly, doubly, and triply
charged ions corresponding to 44 different ganglioside
components identified by automated chip-based
nanoESI-QTOF-MS is listed. From Table 2, it is obvious
that the cerebellar gray matter is dominated by GD1 gly-
coforms. GM1, GM2 and GM3, GD2 and GD3, as well as
GT1 and GQ1 expressing different ceramide portions and
biologically importantO-acetylated and fucosylated GD1,
and GT1 and GQ1 exhibiting high heterogeneity in their
ceramide motifs could also be detected and identified by
the NanoMate approach.
In order to test the feasibility of an efficient ganglioside
sequencing by automated MS to MS/MS mode switching
available on the QTOF mass spectrometer, the triply
charged ion at m/z 708.39 assigned to GT1 (d18:1/18:0)
has been submitted to automatic chip MS infusion fol-
lowed by automatic MS/MS fragmentation in data-de-
pendent acquisition (DDA). In previous work on ganglio-
side fragmentation using capillary-based (2)nanoESI-
QTOF in Z-spray and manual selection for MS/MS [44], a
long signal acquisition time with a sample consumption of
about 50 pmol was necessary to obtain fairly high abun-
dance of fragment ions diagnostic for the structure
assignment of GT1 from a purified fraction. By Nano
ESIchip-automatic fragmentation, within about 1 min of
acquiring in MS/MS mode at a flow rate of 100 nL/min,
approximately 0.5 pmol of material was sprayed and a
sufficient set of fragment ions as fingerprints for structural
elucidation of the molecule was obtained.
Table 2. Composition of single components in the ganglioside mixture from gray matter of normal human cerebellum as
detected by a fully automated (2)nanoESIchip/QTOF-MS.
Type of molecular ion m/z (monoisotopic) Assigned structure
Detected Calculated
[M 1 2Na2 4H]22
[M 2 H]2
611.40
1179.57
611.35
1179.74
GM3 (d18:1/18:0)
[M 2 H]2 1382.60 1382.82 GM2 (d18:1/18:0)
[M 2 2H]22
[M 1 Na 2 2H]2
734.96
1492.78
734.91
1492.81
GD3 (d18:1/18:0)
[M 2 2H]22 748.99 748.93 GD3 (d18:1/20:0)
[M 2 H]2 1518.51 1518.85 GM1, nLM1, and/or LM1 (d18:0/16:0)
[M 2 2H]22
[M 2 H]2
771.98
1544.61
771.93
1544.85
GM1, nLM1, and/or LM1 (d18:1/18:0)
[M 2 2H]22
[M 2 H]2
786.00
1572.61
785.92
1572.85
GM1, nLM1, and/or LM1 (d18:1/20:0)
[M 2 H]2 1690.55 1690.93 Fuc-GM1(d18:1/18:0)
[M 2 H]2 1716.56 1716.94 Fuc-GM1(d18:1/20:1)
[M 2 2H]22 836.46 836.45 GD2 (d18:1/18:0)
[M 2 2H]22 850.47 850.47 GD2 (d18:1/20:0)
[M 2 2H]22
[M 1 Na 2 3H]22
[M 2 H]2
[M 1 Na 2 2H]2
917.44
928.45
1835.62
1857.56
917.48
928.47
1835.96
1857.95
GD1, nLD1, and/or LD1 (d18:1/18:0)
[M 2 2H]22 926.44 926.48 GD1, nLD1, and/or LD1 (t18:0/18:0)
[M 2 2H]22 924.44 924.49 GD1, nLD1, and/or LD1 (d18:1/19:0)
[M 2 2H]22
[M 1 Na 2 3H]22
[M 2 H]2
931.46
942.44
1885.60
931.49
942.48
1885.98
GD1, nLD1, and/or LD1 (d18:1/20:0)
[M 2 2H]22 940.49 940.50 GD1, nLD1, and/or LD1 (t18:0/20:0)
[M 2 2H]22 938.44 938.50 GD1, nLD1, and/or LD1 (d18:1/21:0)
[M 2 2H]22 945.47 945.51 GD1, nLD1, and/or LD1 (d18:1/22:0)
Nomenclature for assignment of ions is according to [63–65]. Reprinted by permission of Elsevier from [48].
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Table 2. Continued
Type of molecular ion m/z (monoisotopic) Assigned structure
Detected Calculated
[M 2 2H]22 954.46 954.51 GD1, nLD1, and/or LD1 (t18:0/22:0)
[M 2 2H]22 952.47 952.52 GD1, nLD1, and/or LD1 (d18:1/23:0)
[M 2 2H]22 958.46a) 958.52 GD1, nLD1, and/or LD1 (d18:1/24:1)
[M 2 2H]22 966.44 966.53 GD1, nLD1, and/or LD1 (d18:1/25:0) or
(d20:1/23:0)
[M 2 2H]22 988.40 988.49 Fuc-GD1 (d18:1/18:2)
[M 2 2H]22 990.40 990.51 Fuc-GD1 (d18:1/18:0)
[M 2 2H]22 999.41a) 999.51 Fuc-GD1 (t18:0/18:0)
[M 2 2H]22 1002.41 1002.51 Fuc-GD1 (d18:1/20:2)
[M 2 2H]22 1004.42 1004.52 Fuc-GD1 (d18:1/20:0)
[M 2 2H]22 1013.44a) 1013.53 Fuc-GD1 (t18:0/20:0)
[M 2 2H]22 1018.99 1019.02 GalNAc-GD1 (d18:1/18:0)
[M 2 2H]22 1032.93a) 1033.03 GalNAc-GD1 (d18:1/20:0)
[M 2 3H]32
[M 2 2H]22
[M 1 Na 2 3H]22
[M 1 2Na2 4H]22
708.39
1062.96
1073.96
1084.93
708.35
1063.03
1074.02
1085.01
GT1 (d18:1/18:0)
[M 2 3H]32
[M 1 Na 2 3H]22
714.41
1082.92
714.35
1083.02
GT1 (t18:0/18:0)
[M 2 3H]32
[M 2 2H]22
[M 1 Na 2 3H]22
[M 1 2Na2 4H]22
717.75
1076.97
1087.95
1098.92
717.69
1077.04
1088.03
1099.02
GT1 (d18:1/20:0)
[M 2 3H]32
[M 1 Na 2 3H]22
723.75
1096.93
723.70
1097.04
GT1 (t18:0/20:0)
[M 1 Na 2 3H]22 1094.95a) 1095.04 GT1 (d18:1/21:0)
[M 2 3H]32
[M 1 Na 2 3H]22
727.11
1101.92
727.04
1102.05
GT1 (d18:1/22:0)
[M 1 Na 2 3H]22 1108.92a) 1109.06 GT1 (d18:1/23:0)
[M 1 Na 2 3H]22 1114.96 1115.06 GT1 (d18:1/24:1)
[M 2 3H]32 722.39 722.35 O-Ac-GT1 (d18:1/18:0)
[M 2 3H]32 731.74 731.70 O-Ac-GT1 (d18:1/20:0)
[M 2 2H]22 1128.95 1129.05 Fuc-GT1 (d18:1/17:0)
[M 2 2H]22 1144.89 1145.06 Fuc-GT1 (t18:0/18:0)
[M 2 2H]22 1159.89 1159.08 Fuc-GT1 (t18:0/20:0)
[M 2 3H]32
[M 1 Na 2 4H]32
[M 1 2Na2 4H]22
[M 1 3Na2 5H]22
805.40
812.73
1230.43
1241.43
805.38
812.71
1230.56
1241.55
GQ1 (d18:1/18:0)
[M 2 3H]32
[M 1 Na 2 4H]32
[M 1 2Na2 4H]22
814.74
822.07
1244.42
814.72
822.05
1244.57
GQ1 (d18:1/20:0)
[M 2 3H]32
[M 1 Na 2 4H]32
819.38a)
826.73a)
819.38
826.71
O-Ac-GQ1 (d18:1/18:0)
d = dihydroxy sphingoid base; t = trihydroxy sphingoid base
a) Low intensity ions. Monoisotopic m/z values of ions are given.
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4 Conclusions and perspectives
Studies upon carbohydrate structure are indispensable to
define complex life systems though they were generally
considered as extremely difficult because of the lack of
the basic efficient technologies commonly used for pro-
teins or nucleic acids. In the past decade, due to the pro-
gress in systems biology and ascendant development of
specific methods and techniques, glycomics could be
introduced as a new concept to follow the genomic and
proteomic ones.
MS is crucial for carbohydrate research, by contributing
basic understanding of how posttranslational events such
as glycosylation affect protein activities. In the past dec-
ade, capillary nanoESI-MS has developed as an effective
means in glycomics. However, several disadvantages of
the method were encountered including low sampling
throughput, potential carryovers, and difficult reproduci-
bility due to the variable shape of the spray tip.
The recent introduction of chip-based ESI-MS in gly-
comics is obviously driven by the higher performance,
sensitivity, and reduced analysis time. To date, two differ-
ent chipESI systems, a thin chip microsprayer and a fully
automated chip-based nanoESI robot, have been cou-
pled each to high performance mass spectrometers and
tested for structural elucidation of glycoconjugates origi-
nating from various biological matrices.
The high sensitivity and ionization efficiency, provided at
nano- and microscale level by these systems, will help to
establish the new chip-based technology for applications
that require identification of unknown, minor components
in complex native mixtures of glycoconjugates. Finally,
nano- and microchip ESI-MS methods are on the way to
become the best suited tools for high-throughput struc-
tural elucidation of carbohydrates indicative of pathologi-
cal states, allowing the chipMS-based glycomics per-
spectives for large-scale use in biomedical research and
clinical diagnostics.
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6 Appendix
Ganglioside abbreviations: LacCer, Galb4Glcb1Cer;
Gg3Cer, GalNAcb4Galb4Glcb1Cer; Gg4Cer, Galb3Gal-
NAcb4Galb4Glcb1Cer; nLc4Cer, Galb4GlcNAcb3-
Galb4Glcb1Cer; GD3, II3-a-(Neu5Ac)2-LacCer; GT3, II
3-a-
(Neu5Ac)3-LacCer; GM2, II
3-a-Neu5Ac-Gg3Cer; GD2, II
3-
a-(Neu5Ac)2-Gg3Cer; GM1a, II
3-a-Neu5Ac-Gg4Cer;
GM1b, IV3-a-Neu5Ac-Gg4Cer; GD1a, IV
3-a-Neu5Ac,II3-
a-Neu5Ac-Gg4Cer; GD1b, II
3-a-(Neu5Ac)2-Gg4Cer;
GT1b, IV3-a-Neu5Ac,II3-a-(Neu5Ac)2-Gg4Cer; GQ1b, IV
3-
a-(Neu5Ac)2,II
3-a-(Neu5Ac)2-Gg4Cer; 3’-nLM1 or nLM1,
IV3-a-Neu5Ac-nLc4Cer; nLD1, disialo-nLc4Cer (IV
3-a-
(Neu5Ac)2-nLc4Cer
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